Newsletter
Transcarent Signs on Northwell, Intermountain and Rush in $200M Funding Round

This Week In Health IT

Transcarent Signs on Northwell, Intermountain and Rush in $200M Funding Round

January 19, 2022

Transcarent Signs on Northwell, Intermountain and Rush in $200M Funding Round

January 19, 2022: You can’t navigate a broken system. Navigators today spend 20% of their time talking about bills. Meet Transcarent. The future of health companies.  They don’t even have bills. Glen Tullman, CEO shares how they’ve invested millions of dollars to create the highest quality care experience possible that challenges the confusing, complex and costly state of the industry. To really address consumer’s needs, Transcarent are focusing on four areas; prescription costs, surgical costs, care at home and complex care. 

Key Points:

00:00:00 – Intro

00:01:40 – Every single day, people aren’t getting the care they need

00:02:00 – Healthcare is more confusing, more complex, more costly than ever before and getting worse

00:07:10 – A lot of people don’t realize that health systems represent 5 of the top 10 largest employers in every state 

00:19:35 – Money means access. When we lower the cost, when we eliminate co-pays, we’re giving more people access.

Transcarent

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Four Authors Untangle When Dad Has Dementia Virtual Q&A on the changes and challenges a dementia diagnosis.